Fireside Chat – Implications of FDA Guidance to Ease Regulatory Enforcement During COVID-19

Time: 9:00 am
day: Day One


• As the FDA opens up to mental health in response to COVID-19, waiving restrictions around digital tools for psychiatric disorders, what are the implications and what does this mean long-term?